Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $89,725.05 -1.85%
Ethereum $3,041.12 -3.06%
BNB $884.20 -1.00%
Optimism $0.30 -3.94%
Arbitrum $0.20 -4.58%
Solana $133.24 -2.90%
Polygon $0.22 +2.77%
Cosmos $2.21 -2.27%
Avalanche $13.23 -4.26%

Bitcoin $89,725.05 -1.85%
Ethereum $3,041.12 -3.06%
BNB $884.20 -1.00%
Optimism $0.30 -3.94%
Arbitrum $0.20 -4.58%
Solana $133.24 -2.90%
Polygon $0.22 +2.77%
Cosmos $2.21 -2.27%
Avalanche $13.23 -4.26%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B